ACN vs PROF · P/E 24, rev $17.60B vs rev $10.7M
Accenture plc (ACN) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. PROF currently screens at market cap $238.7M.
Not investment advice. Open the ACN and PROF stock pages for the full models.
Not investment advice.